Particella

Particella (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing oral lipid nanoparticle technology to deliver nucleic acids to the intestinal epithelium. Its platform enables oral mRNA medicines with repeatable dosing that are non-immunogenic and patient-friendly, targeting a major unmet need in gene therapy drug delivery.